Medicine and Dentistry
Inflammatory Bowel Disease
100%
Patient
89%
Ulcerative Colitis
73%
Cohort Analysis
70%
Vedolizumab
66%
Biological Product
53%
Crohn's Disease
40%
Maintenance Therapy
36%
Analysis
36%
Association
35%
Spontaneous Remission
34%
Biosimilar
33%
Colectomy
33%
Perioperative Medicine
33%
Enalapril Maleate
33%
Adalimumab
33%
Odds Ratio
33%
Infliximab
33%
Self-Directed Learning
33%
Depth Perception
33%
Rhinitis medicamentosa
33%
Predictive Modeling
33%
Abdominal Wall
33%
Infliximab
33%
Hernioplasty
33%
Computed Tomography
33%
Inflammatory Bowel Disease
26%
Biological Therapy
23%
Faecal Calprotectin
23%
COVID-19
22%
Pediatrics
22%
Adverse Event
20%
Abdominal Pressure
20%
Disease
20%
Patient with Inflammatory Bowel Disease
19%
Follow up
17%
Therapeutic Procedure
16%
Cohort Effect
16%
Wound Closure
16%
Laparoscopic Surgery
16%
Medicine
16%
Medical Informatics
16%
Gene Linkage
16%
Doctor of Philosophy
16%
Mental Health
16%
Prevalence
16%
Medical Student
16%
Hernia
13%
Drug
11%
Chemotherapeutic Agent
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
66%
Inflammatory Bowel Disease
43%
Crohn Disease
37%
Remission
37%
Biological Product
37%
Biosimilar Agent
33%
Emergency
33%
Predictive Modeling
33%
Vedolizumab
33%
Ustekinumab
33%
Pig
33%
Abdominal Wall Hernia
33%
Disease Activity
33%
Hernia
33%
Ulcerative Colitis
33%
Disease
23%
Drug
20%
Inflammatory Bowel Disease
18%
Respiratory Virus
16%
Prevalence
16%
Wound
16%
Epidemiology
16%
Calgranulin
12%
Cohort Study
10%
C Reactive Protein
9%
Antibody
8%
Tumor Necrosis Factor
8%
Silicone Gel
8%
Adverse Event
7%
Remission
6%
Ileum Disease
5%
